Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06010901 | A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | unknown | Phase 1 | 75 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06218108 | Multicenter Observational Study Taulí-T1 Classification for the Management of pT1 Rectal Adenocarcinoma(TAUTEM-pT1) | unknown | — | 317 | Corporacion Parc Tauli |
| 1 |
| Jan 23, 2024 |
| clinicaltrials |
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT06216834 | Quality of Life and Psychosocial Status of Young-onset Patients With Rectal Cancer | unknown | — | 300 | Shandong Provincial HospitalOTHER_GOV | 1 | Jan 22, 2024 | clinicaltrials |
| NCT05646043 | PREHAB - Improving Condition Before Surgery | unknown | N/A | 40 | University Hospital OstravaOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT05435313 | Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy | unknown | Phase 2 | 39 | Fudan UniversityOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT04500392 | High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity | unknown | N/A | 1,000 | RenJi HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06200363 | A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer | unknown | Phase 1 | 15 | West China HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06194786 | Diet and Physical Activity Program in Colorectal Cancer Survivor: a Randomized Controlled Trial(DPAP) | unknown | N/A | 260 | Habib Bourguiba University HospitalOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05522738 | Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 46 | Chinese PLA General HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06145230 | A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups | unknown | — | 430 | Wang GuiyuOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT06171854 | caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.(ABACO) | unknown | Phase 2 | 33 | University of Campania Luigi VanvitelliOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT03034473 | Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.(TransValid-A) | unknown | N/A | 200 | University Medical Center GoettingenOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT04338191 | mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer(FANTASTIC) | unknown | Phase 3 | 638 | Sun Yat-sen UniversityOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT05631041 | Effect of Silymarin in Metastatic Colorectal Cancer Patients | unknown | Phase 3 | 64 | Tanta UniversityOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT02473003 | Physical Training and Cancer-a Multicenter Clinical Trial(Phys-Can) | unknown | N/A | 600 | Uppsala UniversityOTHER | 0 | Dec 21, 2023 | clinicaltrials |
| NCT01294072 | Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue | unknown | N/A | 35 | University of LouisvilleOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06172647 | Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer(CMBACT) | unknown | — | 60 | Hospital Mutua de TerrassaOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT04264702 | BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer | unknown | — | 1,788 | Natera, Inc.INDUSTRY | 1 | Dec 12, 2023 | clinicaltrials |
| NCT01477229 | Quality of Life in RECTal Cancer - a Prospective Multicenter Cohort Study(QoLiRECT) | unknown | — | 1,500 | Sahlgrenska University HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT04622176 | Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer(MMURC) | unknown | — | 28 | Sahlgrenska University HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT05328960 | The Pandemic's Effect on Diagnosis and Treatment of Rectal Cancer(CovidRC) | unknown | — | 8,000 | Sahlgrenska University HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT05432934 | Transversus Abdominis Plane Blocks With and Without Dexamethasone(TAP-DEX) | unknown | Phase 1 / Phase 2 | 60 | University of SaskatchewanOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT05578287 | RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer(DETECT) | unknown | Phase 2 | 29 | Sun Yat-sen UniversityOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT03729687 | Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer(LARCT-US) | unknown | Phase 2 | 280 | Uppsala UniversityOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT04865601 | DNA Adductomics for Colorectal Cancer Investigation(adductomics) | unknown | — | 60 | University of CopenhagenOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT05544474 | Definition of Surgical Technique of Lymphadenectomy and Complete Mesocolon Excision for Radical Right Colectomy: a Delphi Consensus | unknown | — | 100 | University of Rome Tor VergataOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05502354 | CRP-guided Transanal Drainage Removal After Rectal Surgery | unknown | N/A | 250 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT04592289 | Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone(REPCA) | unknown | N/A | 622 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04906044 | Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer(STARS-RC03) | unknown | Phase 1 | 46 | The First Hospital of Jilin UniversityOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06134765 | Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer | unknown | Phase 2 | 89 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06135571 | Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer | unknown | — | 3,000 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05839470 | Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer | unknown | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 15, 2023 | clinicaltrials |
| NCT04034459 | FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC(AIO-KRK-0116) | unknown | Phase 2 | 109 | Ludwig-Maximilians - University of MunichOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT06124729 | Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases | unknown | — | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Nov 9, 2023 | clinicaltrials |
| NCT03607370 | Timing for Rectal Surgery After Chemoradiotherapy(ST812) | unknown | N/A | 142 | National Cancer Center Affiliate of Vilnius University Hospital Santaros KlinikosOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT06118047 | Crisaborole Ointment for Skin Toxicity Induced by Cetuximab(COSTIC) | unknown | Phase 2 | 33 | Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06118060 | Acupressure on Postoperative Ileus in Patients With Colorectal Cancer Surgery | unknown | N/A | 104 | Qilu Hospital of Shandong UniversityOTHER | 0 | Nov 7, 2023 | clinicaltrials |
| NCT06120127 | Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence(IMPROVE) | unknown | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06115174 | Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer(CRC - PTX) | unknown | Phase 4 | 44 | Tanta UniversityOTHER | 0 | Nov 2, 2023 | clinicaltrials |
| NCT04753203 | Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients(ALCAP) | unknown | Phase 1 / Phase 2 | 65 | Korean Cancer Study GroupOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT05785325 | RC48-ADC Combined With Bevacizumab in HER2-positive Advanced Colorectal Cancer | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT06108310 | ArTificial inTelligence-based RAdiogenomics in Colon Tumors(ATTRACT) | unknown | — | 500 | University of Roma La SapienzaOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT06104267 | Medical Tai Chi Exercise Healing in Treating mCRC Patients | unknown | N/A | 30 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT06099314 | Fruquintinib in the Cross-line Treatment of Refractory mCRC | unknown | — | 36 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT06096493 | Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum | unknown | — | 200 | South Valley UniversityOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT04878185 | Optimizing Physical Function Before Cancer Surgery in Older People at Risk(CanOptiPhys) | unknown | N/A | 53 | Karolinska InstitutetOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT06091137 | Appendectomy and Colorectal Cancer | unknown | — | 180,000 | Chinese University of Hong KongOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT06089330 | A Study of JMT101 in Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 102 | Shanghai JMT-Bio Inc.INDUSTRY | 0 | Oct 18, 2023 | clinicaltrials |
| NCT03638297 | PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer(PCOX) | unknown | Phase 2 | 29 | Sun Yat-sen UniversityOTHER | 1 | Oct 17, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jan 23, 2024source: clinicaltrials